AUTHOR INDEX

Browse by letter:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search results for: "S"
Results 161 - 170 of 1023 shown below
Schanberg, Saul M
Redford B Williams, Douglas A Marchuk, Kishore M Gadde, John C Barefoot, Katherine Grichnik, Michael J Helms, Cynthia M Kuhn, James G Lewis, Saul M Schanberg, Mark Stafford-Smith, Edward C Suarez, Greg L Clary, Ingrid K Svenson and Ilene C Siegler
Serotonin-Related Gene Polymorphisms and Central Nervous System Serotonin Function
doi:10.1038/sj.npp.1300054
Neuropsychopharmacology 28, 533-541

Abstract | Full text | PDF |
Saul M Schanberg, Vickie F Ingledue, Joanna Y Lee, Yusuf A Hannun and Jorge V Bartolome
PKCalpha Mediates Maternal Touch Regulation of Growth-Related Gene Expression in Infant Rats
doi:10.1038/sj.npp.1300125
Neuropsychopharmacology 28, 1026-1030

Abstract | Full text | PDF |
Schank, Jesse R
Jesse R Schank, Rossella Ventura, Stefano Puglisi-Allegra, Antonio Alcaro, Charlene D Cole, L Cameron Liles, Philip Seeman and David Weinshenker
Dopamine beta-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine
doi:10.1038/sj.npp.1301000
Neuropsychopharmacology aop, -

Schapiro, Mark
Marc J Mentis, Trey Sunderland, Jennifer Lai, Catherine Connolly, Jack Krasuski, Barbara Levine, Judy Friz, Sandeep Sobti, Mark Schapiro and Stanley I Rapoport
Muscarinic Versus Nicotinic Modulation of a Visual Task: A PET Study Using Drug Probes
doi:10.1016/S0893-133X(01)00264-0
Neuropsychopharmacology 25, 555-564

Abstract | Full text | PDF |
Schapiro, Mark B
Kathleen C Raffaele, Sanjay Asthana, Annamaria Berardi, James V Haxby, P Pearse Morris, Mark B Schapiro and Timothy T Soncrant
Differential Response to the Cholinergic Agonist Arecoline among Different Cognitive Modalities in Alzheimer's Disease
doi:10.1016/0893-133X(95)00179-H
Neuropsychopharmacology 15, 163-170

PDF |
Scharfetter, C
F X Vollenweider, K L Leenders, C Scharfetter, P Maguire, O Stadelmann and J Angst
Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis
doi:10.1016/S0893-133X(96)00246-1
Neuropsychopharmacology 16, 357-372

Abstract | PDF |
Scharfetter, Joachim
Bernard Lerer, Ronnen H Segman, Heiner Fangerau, Ann K Daly, Vincenzo S Basile, Roberto Cavallaro, Harald N Aschauer, Robin G McCreadie, Stephanie Ohlraun, Nicol Ferrier, Mario Masellis, Massimiliano Verga, Joachim Scharfetter, Marcella Rietschel, Roger Lovlie, Uriel Heresco Levy, Herbert Y Meltzer, James L Kennedy, Vidar M Steen and Fabio Macciardi
Pharmacogenetics of Tardive Dyskinesia: Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism
doi:10.1016/S0893-133X(02)00293-2
Neuropsychopharmacology 27, 105-119

Abstract | Full text | PDF |
Scharpé, Simon
Michael Maes, Annick Wauters, Robert Verkerk, Paul Demedts, Hugo Neels, Ann Van Gastel, Paul Cosyns, Simon Scharpé and Roger Desnyder
Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism
doi:10.1016/0893-133X(95)00181-C
Neuropsychopharmacology 15, 243-251

Abstract | PDF |
Michael Maes, Ai-hua Lin, Robert Verkerk, Laure Delmeire, An Van Gastel, Marc Van der Planken and Simon Scharpé
Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and without Major Depression
doi:10.1016/S0893-133X(98)00058-X
Neuropsychopharmacology 20, 188-197

Abstract | Full text | PDF |
Michael Maes, Cai Song, Ai-Hua Lin, Stefania Bonaccorso, Gunter Kenis, Raf De Jongh, Eugene Bosmans and Simon Scharpé
Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-bold gamma and Stimulation of Interleukin-10 Secretion
doi:10.1016/S0893-133X(98)00088-8
Neuropsychopharmacology 20, 370-379

Abstract | Full text | PDF |
Marta Kubera, Gunter Kenis, Eugene Bosmans, Simon Scharpé and Michael Maes
Effects of Serotonin and Serotonergic Agonists and Antagonists on the Production of Interferon-bold gamma and Interleukin-10
doi:10.1016/S0893-133X(99)00150-5
Neuropsychopharmacology 23, 89-98

Abstract | Full text | PDF |
Michael Maes, Dirk van West, Nathalie De Vos, Herman Westenberg, Fran Van Hunsel, Dirk Hendriks, Paul Cosyns and Simon Scharpé
Lower Baseline Plasma Cortisol and Prolactin together with Increased Body Temperature and Higher mCPP-Induced Cortisol Responses in Men with Pedophilia
doi:10.1016/S0893-133X(00)00177-9
Neuropsychopharmacology 24, 37-46

Abstract | Full text | PDF |
Scharpe, Simon
Peter D'Hondt, Michael Maes, Josée E Leysen, Walter Gommeren, Lieven Heylen, Frans DeMeyer, Simon Scharpe, Dirk Peeters and Roger Desnyder
Seasonal Variation in Platelet [3H]Paroxetine Binding in Healthy Volunteers
doi:10.1016/0893-133X(95)00183-E
Neuropsychopharmacology 15, 187-198

PDF |
Jan Croonenberghs, Laure Delmeire, Robert Verkerk, Ai-hua Lin, Anisa Meskal, Hugo Neels, Marc Van der Planken, Simon Scharpe, Dirk Deboutte, Greet Pison and Michael Maes
Peripheral Markers of Serotonergic and Noradrenergic Function in Post-Pubertal, Caucasian Males with Autistic Disorder
doi:10.1016/S0893-133X(99)00131-1
Neuropsychopharmacology 22, 275-283

Abstract | Full text | PDF |
Schatzberg, Alan F
Benjamin H Flores, Benjamin H Flores, Heather Kenna, Heather Kenna, Jennifer Keller, Jennifer Keller, Hugh Brent Solvason, Hugh Brent Solvason, Alan F Schatzberg and Alan F Schatzberg
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
doi:10.1038/sj.npp.1300884
Neuropsychopharmacology 31, 628-636

Abstract | Full text | PDF |
Benjamin H Flores, Benjamin H Flores, Heather Kenna, Heather Kenna, Jennifer Keller, Jennifer Keller, Hugh Brent Solvason, Hugh Brent Solvason, Alan F Schatzberg and Alan F Schatzberg
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
doi:10.1038/sj.npp.1300884
Neuropsychopharmacology 31, 628-636

Abstract | Full text | PDF |
A John Rush, Helena C Kraemer, Harold A Sackeim, Maurizio Fava, Madhukar H Trivedi, Ellen Frank, Philip T Ninan, Michael E Thase, Alan J Gelenberg, David J Kupfer, Darrel A Regier, Jerrold F Rosenbaum, Oakley Ray and Alan F Schatzberg
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
doi:10.1038/sj.npp.1301131
Neuropsychopharmacology 31, 1841-1853

Abstract | Full text | PDF |
Jennifer Keller and Alan F Schatzberg
Reply: Clinical and Biological Effects of Mifepristone Treatment for Psychotic Treatment
doi:10.1038/sj.npp.1301171
Neuropsychopharmacology 31, 2795-2797

Abstract | Full text | PDF |
Alan I Green and Alan F Schatzberg
Joseph J Schildkraut, 1934–2006
doi:10.1038/sj.npp.1301474
Neuropsychopharmacology 32, 1855-1856

Abstract | Full text | PDF |
Steven E Lindley, Tasha G Bengoechea, Alan F Schatzberg and Dona L Wong
Glucocorticoid Effects on Mesotelencephalic Dopamine Neurotransmission
doi:10.1016/S0893-133X(98)00103-1
Neuropsychopharmacology 21, 399-407

Abstract | Full text | PDF |
Schaus, John M
Fumihiko Yasuno, Amira K Brown, Sami S Zoghbi, Joseph H Krushinski, Eyassu Chernet, Johannes Tauscher, John M Schaus, Lee A Phebus, Amy K Chesterfield, Christian C Felder, Robert L Gladding, Jinsoo Hong, Christer Halldin, Victor W Pike and Robert B Innis
The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain
doi:10.1038/sj.npp.1301402
Neuropsychopharmacology 33, 259-269

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | previous Previous | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT